-+ 0.00%
-+ 0.00%
-+ 0.00%

SANOFI AND THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE SIGN LETTER OF INTENT FOR SARCLISA®(ISATUXIMAB), A STEP TOWARD PUBLIC ACCESS FOR NEWLY DIAGNOSED, TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA PATIENTS

Reuters·11/16/2026 14:15:22

Please log in to view news